Canton Strategic Holdings Inc
NASDAQ:CNTN · NASDAQ Capital Market
-$0.32 today
Vol 2.76M · Avg 0.69M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NASDAQ:CNTN · Revenue to Net Income
Key Ratios
Analysis
$0 of revenue converted into -$80.7M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.36, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $725.6M | $804.0M | $882.4M |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | $8.9B | $7.6B | $6.2B |
| Gross Margin | — | — | — | — | — | 9.8% | 28.9% | 38.3% |
| Research & Development | $3.1M -51.9% | $6.4M +79.6% | $3.6M +56.2% | $2.3M +23.6% | $1.8M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $17.0M +181.9% | $6.0M +2.5% | $5.9M +28.1% | $4.6M +237.2% | $1.4M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $20.1M +61.7% | $12.4M +31.5% | $9.5M +37.4% | $6.9M +114.5% | $3.2M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $24.8K | $0 -100.0% | $152.6K -33.2% | $228.5K | $0 | $374.2M | $1.2B | $631.8M |
| EBITDA | -$42.1M -244.4% | -$12.2M -33.5% | -$9.1M -37.5% | -$6.7M -383.8% | -$1.4M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | — | — | — | — | — | 5.6% | 46.3% | 42.0% |
| Operating Income | -$20.1M -61.7% | -$12.4M -31.5% | -$9.5M -37.4% | -$6.9M -114.5% | -$3.2M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | — | — | — | — | — | 16.6% | 24.1% | 22.0% |
| Interest Income | $41.4K -83.4% | $249.9K +63.7% | $152.6K | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $28.3K +107.1% | $13.7K -17.1% | $16.5K -99.0% | $1.6M +91.4% | $831.3K | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$22.0M -9412.1% | $236.2K +73.5% | $136.1K +108.6% | -$1.6M -258.9% | $1.0M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$42.1M -245.2% | -$12.2M -30.9% | -$9.3M -10.0% | -$8.5M -284.0% | -$2.2M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | — | — | — | — | — | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | -$6.2M | $0 | $0 | $0 | $0 | $1.3B | -$1.6B | $745.2M |
| Net Income | -$35.9M -194.5% | -$12.2M -30.9% | -$9.3M -10.0% | -$8.5M -284.0% | -$2.2M | $4.9B | $4.8B | $4.7B |
| Net Margin | — | — | — | — | — | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$1 +88.1% | -$9 +91.2% | -$107 +61.9% | -$281 -285.6% | -$73 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$1 +88.1% | -$9 +91.2% | -$107 +61.9% | -$281 -285.6% | -$73 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $32.0M +2372.4% | $1.3M +1389.5% | $87.0K +188.4% | $30.2K -0.4% | $30.3K | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $32.0M +2372.4% | $1.3M +1389.5% | $87.0K +188.4% | $30.2K -0.4% | $30.3K | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Adlai Nortye Ltd.
NASDAQ:ANL
$536.37M
Apollomics, Inc.
APLM
$17.89M
Lunai Bioworks Inc.
LNAI
$17.55M
Moleculin Biotech, Inc.
MBRX
$15.37M
BioLineRx Ltd.
BLRX
$13.63M
Adaptimmune Therapeutics plc
ADAP
$12.53M
SeaStar Medical Holding Corporation
ICU
$8.71M
Ainos, Inc.
AIMD
$8.60M
GeoVax Labs, Inc.
GOVX
$1.15M
Aditxt, Inc.
ADTX
$429.00
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does CNTN generate?
Canton Strategic Holdings Inc (CNTN) reported $0.00 of revenue in fiscal 2025.
Is CNTN profitable?
Canton Strategic Holdings Inc (CNTN) reported -$35,916,250.00 of net income.
Explore More
Continue the stock analysis
Jump to another research area for this company.